Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/23/2009EP2134365A1 Compositions and methods for inhibiting tumor cell growth
12/23/2009EP2134364A2 Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors
12/23/2009EP2134355A2 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
12/23/2009EP2134353A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
12/23/2009EP2134350A1 Device and method for intraocular drug delivery
12/23/2009EP2134349A1 Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseases
12/23/2009EP2134348A1 Weekly administration of dipeptidyl peptidase inhibitors
12/23/2009EP2134347A2 Compositions and methods for preventing and treating mucositis and weight loss
12/23/2009EP2134346A1 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
12/23/2009EP2134345A2 Triazolquinolonic derivatives with antimycobacterial activity
12/23/2009EP2134344A1 Reduction of adverse events.after percutaneous intervention by use of a thrombin receptor antagonist
12/23/2009EP2134343A2 Pyrrolo-pyridine kinase modulators
12/23/2009EP2134342A2 Monocyclic anilide spirolactam cgrp receptor antagonists
12/23/2009EP2134341A2 Method of treating cell proliferative disorders using growth hormone secretagogues
12/23/2009EP2134338A1 Hydroquinone ansamycin formulations
12/23/2009EP2134337A1 Novel burn treatment composition
12/23/2009EP2134336A1 Benzofuran-derived hiv protease inhibitors
12/23/2009EP2134334A1 Nanoparticulated anesthetic composition for topic use
12/23/2009EP2134327A1 Pharmaceutical compositions of poorly soluble drugs
12/23/2009EP2134326A1 Pharmaceutical compositions comprising irbesartan
12/23/2009EP2134325A2 Stable solid dosage forms of an antidepressant
12/23/2009EP2134322A1 Intravesical apaziquone administration following transurethral resection for treating cancer
12/23/2009EP2134321A2 Orally administrable films
12/23/2009EP2134176A1 Compounds and methods for enhancing mhc class ii therapies
12/23/2009EP2134175A1 Inhibitors of akt activity
12/23/2009EP2134174A1 Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
12/23/2009EP2134172A2 Restrictive agonist of toll-like receptor 3 (tlr3)
12/23/2009EP2134171A2 Compositions and methods for bone formation and remodeling
12/23/2009EP1959951B1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
12/23/2009EP1919896B1 Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands.
12/23/2009EP1888552B1 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
12/23/2009EP1879901B1 Pyrrolobenzodiazepines
12/23/2009EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
12/23/2009EP1874778B1 Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
12/23/2009EP1838295B1 Anthelmintic composition
12/23/2009EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
12/23/2009EP1720859B1 Chemokine receptor antagonists
12/23/2009EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009EP1682550B1 Substituted naphthyridinone derivatives
12/23/2009EP1613302B1 Preserved and stable compositions containing peptide copper complexes and methods related thereto
12/23/2009EP1608654B1 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/23/2009EP1562941B1 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
12/23/2009EP1562569B1 Antifungal medicaments comprising arylamidine derivatives
12/23/2009EP1551415B1 Oral pharmaceutical composition comprising 15-hydroxytestosterone and its analogues
12/23/2009EP1549651B1 Pyrimidopyrimidones as kinase inhibitors
12/23/2009EP1534390B1 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene hydrazino -2'-hydroxy- 1,1'-biphenyl -3-carboxylic acid bis-(monoethanolamine)
12/23/2009EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
12/23/2009EP1485343B1 Amorphous hmg-coa reductase inhibitors of desired particle size
12/23/2009EP1483251B1 C3-cyano epothilone derivatives
12/23/2009EP1450822B1 Polyalkylene oxide conjugates of thiol-containing drugs
12/23/2009EP1420787B1 Ophthalmic composition comprising an ascomycin
12/23/2009EP1356816B1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
12/23/2009EP1341538B1 Medicament compositions with salts of tiotropium and epinastin for the therapy of respiratory diseases
12/23/2009EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors
12/23/2009EP1274861B1 Compositions and methods for identifying and targeting cancer cells
12/23/2009EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform
12/23/2009EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
12/23/2009EP1232757B1 Agents for diseases in association with decrease in bone mass
12/23/2009EP1164874B1 Use of negatively charged, non-digestible polysaccharide hydrolysates for reducing transport through tight junctions of the intestin
12/23/2009CN101611058A PRLR-specific antibody and uses thereof
12/23/2009CN101611046A Antiviral nucleoside analogs
12/23/2009CN101611041A Fused heterocyclic compound
12/23/2009CN101611039A HCV NS3 protease inhibitors
12/23/2009CN101611038A 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
12/23/2009CN101611037A Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process
12/23/2009CN101611036A Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
12/23/2009CN101611035A Pyrazolopyrimidine compound
12/23/2009CN101611034A New triazabenzo[a]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
12/23/2009CN101611033A Indole derivatives as S1P1 receptor agonists
12/23/2009CN101611032A Thienyl-containing glycopyranosyl derivatives as antidiabetics
12/23/2009CN101611029A Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl) phenoxy)methyl)quinoline
12/23/2009CN101611028A Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/23/2009CN101611027A Indol-2-yl-piperazin-1-yl-methanone derivatives
12/23/2009CN101611025A 5,6-ring annulated indole derivatives and methods of use thereof
12/23/2009CN101611024A Crystalline forms of aryl-substituted pyrazole-amide compounds
12/23/2009CN101611023A 1-phenyl 1-thio-d-glucitol derivative
12/23/2009CN101611019A Macrocyclic factor VIIa inhibitors useful as anticoagulants
12/23/2009CN101611015A Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
12/23/2009CN101611013A Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
12/23/2009CN101611012A Cycloalkylamine substituted isoquinoline derivatives
12/23/2009CN101611011A Chemical compounds
12/23/2009CN101611009A Quinoline derivatives
12/23/2009CN101611006A Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide
12/23/2009CN101611005A Substituted acetophenones useful as PDE4 inhibitors
12/23/2009CN101611002A 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
12/23/2009CN101610998A 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
12/23/2009CN101610997A Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/23/2009CN101610996A Inhibitors of histone deacetylase and prodrugs thereof
12/23/2009CN101610815A Cream-gel comprising at least one retinoid and benzoyl peroxide
12/23/2009CN101610813A Quinuclidinol derivatives as muscarinic receptor antagonists
12/23/2009CN101610789A Methods, compositions, and kits for treating pain and pruritis
12/23/2009CN101610784A PTH formulations and methods of use
12/23/2009CN101610779A 5ht4受体拮抗药 5ht4 receptor antagonist
12/23/2009CN101610777A Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative
12/23/2009CN101610776A Combination comprising CNDAC (2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent
12/23/2009CN101610775A Analgesic agent comprising cyclic phosphatidic acid derivative
12/23/2009CN101610774A Method of treating demyelination diseases
12/23/2009CN101610773A Compounds and uses thereof
12/23/2009CN101610772A Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
12/23/2009CN101610771A Therapeutic agent for liver cancer
1 ... 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 ... 7860